128 related articles for article (PubMed ID: 11426338)
1. Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors.
Hacker UT; Gerner FM; Büning H; Hutter M; Reichenspurner H; Stangl M; Hallek M
Gene Ther; 2001 Jun; 8(12):966-8. PubMed ID: 11426338
[TBL] [Abstract][Full Text] [Related]
2. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.
Severin T; Zieger B; Sutor AH
Semin Thromb Hemost; 2002 Oct; 28(5):447-54. PubMed ID: 12420240
[TBL] [Abstract][Full Text] [Related]
4. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
Burgess JK; Chong BH
Eur J Haematol; 1997 Apr; 58(4):279-85. PubMed ID: 9186540
[TBL] [Abstract][Full Text] [Related]
5. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
Zmuda K; Neofotistos D; Ts'ao CH
Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
[TBL] [Abstract][Full Text] [Related]
7. [Delayed hypersensitivity to heparins and heparinoids].
Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
Grassegger A; Fritsch P; Reider N
Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of efficient recombinant adeno-associated virus transduction in retinal pigment epithelial cells.
Lai YK; Rolling F; Baker E; Rakoczy PE
Exp Cell Res; 2001 Jul; 267(2):184-92. PubMed ID: 11426937
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study.
de Pont AC; Hofstra JJ; Pik DR; Meijers JC; Schultz MJ
Crit Care; 2007; 11(5):R102. PubMed ID: 17854496
[TBL] [Abstract][Full Text] [Related]
11. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
Cleveland KW
Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
[No Abstract] [Full Text] [Related]
12. Inhibition of thrombin generation in recalcified plasma.
Stief TW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):751-60. PubMed ID: 17982316
[TBL] [Abstract][Full Text] [Related]
13. Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.
Shapiro M; Cohen J; Inbal A; Singer P
Isr Med Assoc J; 2009 Mar; 11(3):188-90. PubMed ID: 19544713
[No Abstract] [Full Text] [Related]
14. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
[No Abstract] [Full Text] [Related]
15. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
16. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors.
Handa A; Muramatsu SI; Qiu J; Mizukami H; Brown KE
J Gen Virol; 2000 Aug; 81(Pt 8):2077-2084. PubMed ID: 10900047
[TBL] [Abstract][Full Text] [Related]
17. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
Fernández JA; Petäjä J; Griffin JH
Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
[TBL] [Abstract][Full Text] [Related]
18. Danaparoid: an antithrombotic agent without major impact on triglyceride hydrolysis capacity in humans.
van Barlingen HH; van Beek A; Erkelens DW; de Bruin TW
J Intern Med; 1997 Aug; 242(2):125-9. PubMed ID: 9279289
[TBL] [Abstract][Full Text] [Related]
19. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors.
Kofler DM; Büning H; Mayr C; Bund D; Baumert J; Hallek M; Wendtner CM
Gene Ther; 2004 Sep; 11(18):1416-24. PubMed ID: 15269708
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
Lindhoff-Last E; Bauersachs R
Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
